FDA — authorised 5 September 2014
- Application: NDA205874
- Marketing authorisation holder: KERYX BIOPHARMS
- Local brand name: AURYXIA
- Indication: TABLET — ORAL
- Status: approved
FDA authorised Ferric Citrate 1 gram Oral Tablet on 5 September 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 5 September 2014; FDA has authorised it.
KERYX BIOPHARMS holds the US marketing authorisation.